- Home
- Life Sciences
- Diagnostics
- In Vitro Diagnostic
- World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
$ 4 500
- January 2013
- by Kalorama Information
- 880
Summary
Table of Contents
View Report
Search Inside
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics.
Comprehensive Coverage of the Molecular Diagnostics Industry
The report not only contains current market data for business planning, it goes beyond the numbers to fully assess what is going on in the market and why. Since the last edition of this report, a lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. As part of its coverage, the report includes the following:
- Over 800 Pages of Detailed Market Coverage
- Over 55 Tables Makes Market Analysis More Accessible
- Current Market Size and Forecast 2012-2017 for Several Molecular IVD Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
- Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
- Over 200 Profiles of Molecular Diagnostic Competitors
- Recent Mergers and Acquisitions
- Revenues of Test Service Companies
- Geographic Breakout of the Molecular Diagnostics Market by Region (North America, Europe, China, Japan, ROW)
- Sample Prep Market, 2012 and 2017
- Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2012 and 2017
More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and have agreed to pay for them. A desire for better and faster test results, a preference for tests that are aimed at the patent, renewed interest in IVD in general and more particularly in molecular IVD has led to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.
Over 200 Companies Profiled and Ranked
Kalorama provides profiles of over 200 companies participating in the market. All of these companies have different strategies and compete in different areas, and Kalorama acknowledges this by separating the companies in a triage system based on where they stand in the molecular in vitro diagnostics market.
- "IVD Leaders" - The top IVD companies participating in molecular diagnostics as well as dominating the rest of testing.
- "Molecular Diagnostics Leaders" -The top companies focused on molecular testing.
- "Molecular Diagnostics Participants"- Molecular diagnostic companies that are by now established in the market
- "Promising Companies"- Those companies that have potential with an innovative approach
- "Molecular Diagnostics Newcomers"- IVD Companies that have novel or interesting approaches to keep an eye on
- "Platform Innovators"- Companies that have developed new platform technologies
- "Information Technology Companies" - Molecular testing relies on strong information systems to handle data. These companies are in the forefront.
- "Sample Prep Leaders" - Companies focused on sample preparation for molecular diagnostics
- "Specialist Companies" - In various areas (microbiology, histology, blood banking, etc)
A Realistic Look at The Need-To-Know Trends
Molecular diagnostics is a complicated market that requires a thorough analysis to understand. Many reports make bold predictions which later are proved incorrect by market events. In this report, Kalorama Information provides revenues and market forecasts, but also looks deeply at some of the trends in the market and what might impact results in the future. The report summarizes what is working and what is not working in the past few years.
- Sequencing Hype and Reality: Innovations in DNA Sequencing, Key Players and its Future in Clinical Medicine
- Pharmacodiagnostics and Where it Stands in 2013
- The Latest Growth Numbers of LDTs, regulatory activity, and their impact on the Market
- IVD Directive Update
- Patent Issues
- Healthcare Reform, Accountable Care Organizations and Reimbursement Trends
- Improvements in Platforms
- Developments in ISH testing, Tissue Microarrays and Mass Spectroscopy
- Integrated Sample-to-Results Testing
Market size and forecasts in the report are for manufacturer's revenues. Secondary and primary resources, including: trade publications, annual report and interviews with key executives in molecular diagnostics were used for this study.
Comprehensive Coverage of the Molecular Diagnostics Industry
The report not only contains current market data for business planning, it goes beyond the numbers to fully assess what is going on in the market and why. Since the last edition of this report, a lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. As part of its coverage, the report includes the following:
- Over 800 Pages of Detailed Market Coverage
- Over 55 Tables Makes Market Analysis More Accessible
- Current Market Size and Forecast 2012-2017 for Several Molecular IVD Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
- Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
- Over 200 Profiles of Molecular Diagnostic Competitors
- Recent Mergers and Acquisitions
- Revenues of Test Service Companies
- Geographic Breakout of the Molecular Diagnostics Market by Region (North America, Europe, China, Japan, ROW)
- Sample Prep Market, 2012 and 2017
- Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2012 and 2017
More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and have agreed to pay for them. A desire for better and faster test results, a preference for tests that are aimed at the patent, renewed interest in IVD in general and more particularly in molecular IVD has led to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.
Over 200 Companies Profiled and Ranked
Kalorama provides profiles of over 200 companies participating in the market. All of these companies have different strategies and compete in different areas, and Kalorama acknowledges this by separating the companies in a triage system based on where they stand in the molecular in vitro diagnostics market.
- "IVD Leaders" - The top IVD companies participating in molecular diagnostics as well as dominating the rest of testing.
- "Molecular Diagnostics Leaders" -The top companies focused on molecular testing.
- "Molecular Diagnostics Participants"- Molecular diagnostic companies that are by now established in the market
- "Promising Companies"- Those companies that have potential with an innovative approach
- "Molecular Diagnostics Newcomers"- IVD Companies that have novel or interesting approaches to keep an eye on
- "Platform Innovators"- Companies that have developed new platform technologies
- "Information Technology Companies" - Molecular testing relies on strong information systems to handle data. These companies are in the forefront.
- "Sample Prep Leaders" - Companies focused on sample preparation for molecular diagnostics
- "Specialist Companies" - In various areas (microbiology, histology, blood banking, etc)
A Realistic Look at The Need-To-Know Trends
Molecular diagnostics is a complicated market that requires a thorough analysis to understand. Many reports make bold predictions which later are proved incorrect by market events. In this report, Kalorama Information provides revenues and market forecasts, but also looks deeply at some of the trends in the market and what might impact results in the future. The report summarizes what is working and what is not working in the past few years.
- Sequencing Hype and Reality: Innovations in DNA Sequencing, Key Players and its Future in Clinical Medicine
- Pharmacodiagnostics and Where it Stands in 2013
- The Latest Growth Numbers of LDTs, regulatory activity, and their impact on the Market
- IVD Directive Update
- Patent Issues
- Healthcare Reform, Accountable Care Organizations and Reimbursement Trends
- Improvements in Platforms
- Developments in ISH testing, Tissue Microarrays and Mass Spectroscopy
- Integrated Sample-to-Results Testing
Market size and forecasts in the report are for manufacturer's revenues. Secondary and primary resources, including: trade publications, annual report and interviews with key executives in molecular diagnostics were used for this study.
ASK INFO SPECIALIST 24/7
Robyn - online now
00 1 718 213 49 04
Send Message @Robyn
Share
Global In Vitro Diagnostic Industry : Latest Reports
2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic ...
2013 Analysis of the Global Coagulation Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new 302-page report from Venture Planning Group provides analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and ...
2013 Analysis of the Global Clinical Chemistry and Immunodiagnostic Markets: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profilels of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new 464-page report from Venture Planning Group provides analysis of the global clinical chemistry and immunodiagnostic markets, including emerging tests, technologies, instrumentation, sales forecasts ...
More Reports:
In Vitro Diagnostic in China (34)
Global In Vitro Diagnostic Industry : Latest Downloads
In Vitro Diagnostic Market Brief
- Industry report
- April 2013
- 4 pages
... Middleware: created to aid market planners interested in strengthen- ing their firm S position while accelerating the growth of the informatics segment of the clinical laboratory. Sales effort: developed ...
In Vitro Diagnostic Industry Brief
- Industry report
- April 2013
- 5 pages
Tissue Culture Business Brief
- Industry report
- March 2013
- 17 pages
... To remain open for acceptance till the next working day at the same time. Financial bid will be opened only for technically accepted tenders for further evaluation. Tender form for tissue culture ...
In Vitro Diagnostic Market Analysis
3 months agoMicrobiology : Innovation And Technology Tren ...
5 months agoWorld In Vitro Diagnostic Industry Brief
5 months agoIn Vitro Sector Brief
9 months agoTissue Culture Sector Brief
9 months agoIn Vitro Industry Brief
9 months agoIn Vitro Industry Brief
9 months agoMore Reports:
In Vitro Diagnostic in Germany (5)
Related Market Segments :
Molecular Assay
In Vitro Instrument
Laboratory Equipment
Molecular Diagnostic
Histology
Company Reports
ref:plp2013
Reportlinker.com © Copyright 2013. All rights reserved.
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.
